Thursday, November 12, 2026

Articles by Country

December 24, 2018

Argentina

Bangladesh

Belgium

Brazil

Colombia

China

Dominican Republic

Egypt

Equador

Ethiopia

Haiti

Panama

Philippines

France

Georgia

Germany

Greece

India

Indonesia

Israel

Italy

Kenya

North korea

Myanmar

Nigeria

Norway

Pakistan

Portugal

Romania

Russia

Rwanda

Saudi Arabia

Scotland

Serbia

South Africa

Spain

South Sudan

Switzerland

Turkey

Ukraine

United Kingdom

United States of America

Uruguay

Venezuela

Categories

Uncategorized

What we know · the intelligence behind this page

Live from the substrate

What we're seeing

Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring

A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.

Our read on the data ›

Signals we're tracking

EPKINLY Regulatory-Clinical Success Cascade

High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.

Patterns we're watching ›

Where sources disagree

Ford Motor Company

Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.

We flag conflicts openly ›

Recently verified

✓ Checked against the original source

4,995

facts traced to their source — and we flag the ones that don't hold up.

101 entities tracked4,995 facts checked against source5,565 source documents archived

Query this data → isubstrate.com